This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Inflammatory Bowel Disease During Childhood ... A new study revealed an increased risk of cancer and early death ... (13 May 2019)
Fracture Risk Tool Is Useful in Women with ... The FRAX®tool takes into account certain factors to determine ... (13 May 2019)
Antibiotic cocktail stops cancer cells from ... Scientists in Salford, UK have found a way to make cancer stem ... (13 May 2019)
Statins Linked to Lower Risk of Early Death ... Use of statins before or after a diagnosis of colorectal cancer ... (13 May 2019)
Do Sunscreen Compromises Vitamin D Levels? Sunscreen can reduce the sun’s adverse effects, but there are ... (13 May 2019)

World Preeclampsia Day - May 22, 2017

Rate this item
(0 votes)

NICE recommends Roche Diagnostic’s blood test to help rule-out pre-eclampsia in women between their 20th and 35th week of pregnancy. This blood test is more specifically known as the Elecsys immunoassay sFIt-1/PIGF ratio (Roche Diagnostics).

The sFlt-1/PIGF ratio

 

  • The Elecsys® sFlt-1 and Elecsys® PlGF immunoassays are a reliable automated laboratory test to be used as an aid in the diagnosis of Preeclampsia
  • A simple blood test can now deliver clear, reliable results to help identifying patients at risk for potentially life threatening complications
  • The ELecsys sFlt-1 and PlGF biomarkers have the potential to offer major advances and the diagnosis and management of Preeclampsia

Click here for the video link

Read 3429 times Last modified on Tuesday, 23 May 2017 20:22

Media

Click to view the video
More in this category: Erbitux »

Vivian

Highlights

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…